US Patent Issued to Amunix Pharmaceuticals on March 31 for "Compositions targeting epidermal growth factor receptor and methods for making and using the same" (German, American Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,159, issued on March 31, was assigned to Amunix Pharmaceuticals Inc. (South San Francisco, Calif.).

"Compositions targeting epidermal growth factor receptor and methods for making and using the same" was invented by Viktoriya Dubrovskaya (San Francisco), Eric Johansen (Oakland, Calif.), Sina Khorsand (El Cerrito, Calif.), Lucas Liu (San Bruno, Calif.), Volker Schellenberger (Palo Alto, Calif.), Milton To (San Lorenzo, Calif.), Tracy Young (Belmont, Calif.), Andre Frenzel (Braunschweig, Germany) and Philipp Kuhn (Braunschweig, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure describes antibody binding domains for cluster of diff...